Energetic, structural, and antimicrobial analyses of β-lactam side chain recognition by β-lactamases

AbstractBackground: Penicillins and cephalosporins are among the most widely used and successful antibiotics. The emergence of resistance to these β-lactams, most often through bacterial expression of β-lactamases, threatens public health. To understand how β-lactamases recognize their substrates, it would be helpful to know their binding energies. Unfortunately, these have been difficult to measure because β-lactams form covalent adducts with β-lactamases. This has complicated functional analyses and inhibitor design.Results: To investigate the contribution to interaction energy of the key amide (R1) side chain of β-lactam antibiotics, eight acylglycineboronic acids that bear the side chains of characteristic penicillins and cephalosporins, as well as four other analogs, were synthesized. These transition-state analogs form reversible adducts with serine β-lactamases. Therefore, binding energies can be calculated directly from Ki values. The Ki values measured span four orders of magnitude against the Group I β-lactamase AmpC and three orders of magnitude against the Group II β-lactamase TEM-1. The acylglycineboronic acids have Ki values as low as 20 nM against AmpC and as low as 390 nM against TEM-1. The inhibitors showed little activity against serine proteases, such as chymotrypsin. R1 side chains characteristic of β-lactam inhibitors did not have better affinity for AmpC than did side chains characteristic of β-lactam substrates. Two of the inhibitors reversed the resistance of pathogenic bacteria to β-lactams in cell culture. Structures of two inhibitors in their complexes with AmpC were determined by X-ray crystallography to 1.90 Å and 1.75 Å resolution; these structures suggest interactions that are important to the affinity of the inhibitors.Conclusions: Acylglycineboronic acids allow us to begin to dissect interaction energies between β-lactam side chains and β-lactamases. Surprisingly, there is little correlation between the affinity contributed by R1 side chains and their occurrence in β-lactam inhibitors or β-lactam substrates of serine β-lactamases. Nevertheless, presented in acylglycineboronic acids, these side chains can lead to inhibitors with high affinities and specificities. The structures of their complexes with AmpC give a molecular context to their affinities and may guide the design of anti-resistance compounds in this series